Refining risk stratification: adiposity-integrated atherogenic indices for predicting incident metabolic syndrome in a prospective cohort
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background The atherogenic index of plasma (AIP) is an established marker for lipid-related risk but inherently overlooks central obesity, a core component of metabolic syndrome (MetS). We investigated whether integrating AIP with anthropometric measures (BMI, waist circumference [WC], waist-to-height ratio [WHtR] ) improves risk stratification for incident MetS. Methods This prospective cohort study analyzed 3,835 adults from the China Health and Retirement Longitudinal Study (CHARLS; 2011–2015). The predictive performance of baseline AIP and three integrated indices (AIP–BMI, AIP–WC, AIP–WHtR) was assessed using multivariable logistic regression, ROC curves, Net Reclassification Improvement (NRI), and Integrated Discrimination Improvement (IDI). Findings were externally validated in an independent 11-year prospective cohort of 131 eligible participants free of MetS at baseline. Results During the 4-year follow-up, all adiposity-integrated indices were positively associated with incident MetS. Comparing the highest to the lowest quartile, AIP–BMI (OR = 3.37; 95% CI: 2.26–5.06) and AIP–WC (OR = 3.06; 95% CI: 2.06–4.58) demonstrated stronger associations than AIP alone (OR = 2.55; 95% CI: 1.70–3.84). The modified indices significantly improved predictive discrimination and reclassification; AIP-BMI showed the highest AUC of 0.656 (95% CI: 0.633–0.678), yielding an IDI of 0.0094 (95% CI: 0.0067–0.0122) and an NRI of 0.0465 (95% CI: 0.0262–0.0667). Subgroup analyses revealed more robust associations among individuals without pre-existing dyslipidemia or hypertension. In the independent validation cohort, baseline AIP strongly predicted incident MetS, with an adjusted relative risk (RR) of 1.57 (95% CI: 1.34–1.84, p < 0.001). A synergistic effect between elevated AIP and central obesity was confirmed, with 82% of the incident MetS risk attributable to their biological interaction. Conclusions Integrating AIP with simple anthropometric measures significantly improves risk reclassification for incident MetS compared to AIP alone. The 11-year prospective validation robustly confirms the utility of AIP as an independent and early predictor, and these non-redundant indices offer practical, cost-effective tools for population-based cardiometabolic risk stratification. Clinical trial number Not applicable.
Source: BMC Cardiovascular Disorders
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: atherogenic index of plasma, metabolic syndrome, abdominal obesity, waist circumference, waist-to-height ratio, body mass index, risk stratification, dyslipidemia, hypertension, lipid profile, China Health and Retirement Longitudinal Study, prospective cohort, risk prediction model, integrated discrimination improvement, net reclassification improvement, external validation
Open Access status: gold
Estimated APC paid: $3,090
OpenAlex ID: W7225904354
